Leap Therapeutics Transforms into Cypherpunk Technologies
I'm PortAI, I can summarize articles.
Leap Therapeutics has transformed into Cypherpunk Technologies Inc., focusing on antibody therapies for cancer and digital assets. In its Q3 earnings report, the company reported a net loss of $3.3 million, with reduced operating expenses. It raised approximately $58.9 million through a private placement to support its new digital asset strategy, particularly Zcash. Despite the capital raise, Cypherpunk Technologies faces challenges in achieving profitability while balancing its biopharmaceutical and digital asset operations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments